BridgeMD
New treatment option for Sudden Unexplained Infant Death
Official title Advanced Wireless Sensors for Neonatal Care in the Delivery Room
ClinicalTrials.gov ID: NCT06693817
What this study is testing
- What it's testing
- The goals of this observational study is to assess whether a new advanced wireless skin sensor vital sign monitoring system can effectively monitor the vital signs of healthy newborn infants (≥ 35 weeks gestational age). The main aims of this Study are to: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 42. Healthy volunteers may be eligible.
You may be able to join if
- Newborns ≥35 weeks (gestational age)
- Newborns determined to be clinically stable at delivery
- Newborns with no skin abnormalities
You likely can't join if
- Newborns ≤ 35 weeks (gestational age)
- Newborns determined to not be clinically stable at delivery
- Newborns with Skin abnormalities
The study team makes the final eligibility decision.
Where it's taking place
- Londrina, Paraná, Brazil
- Montreal, Quebec, Canada
- Ponderano, BI, Italy
- Lucerne, Canton of Lucerne, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 weeks to 42 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Londrina, Paraná, Brazil; Montreal, Quebec, Canada; Ponderano, BI, Italy; Lucerne, Canton of Lucerne, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.